APA (7th ed.) Citation

Schellenberg, J. J., Adam, H. J., Baxter, M. R., Karlowsky, J. A., Golden, A. R., Martin, I., & Zhanel, G. G. (2025). Comparing serotype coverage of pneumococcal vaccines with PCV21 (V116), a new 21-valent conjugate pneumococcal vaccine, and the epidemiology of its eight unique Streptococcus pneumoniae serotypes (15A, 15C, 16F, 23A, 23B, 24F, 31 and 35B) causing invasive pneumococcal disease in adult patients in Canada: SAVE study, 2018–21 Open Access. Journal of Antimicrobial Chemotherapy (JAC), 80(5), 1377. https://doi.org/10.1093/jac/dkaf085

Chicago Style (17th ed.) Citation

Schellenberg, John J., Heather J. Adam, Melanie R. Baxter, James A. Karlowsky, Alyssa R. Golden, Irene Martin, and George G. Zhanel. "Comparing Serotype Coverage of Pneumococcal Vaccines with PCV21 (V116), a New 21-valent Conjugate Pneumococcal Vaccine, and the Epidemiology of Its Eight Unique Streptococcus Pneumoniae Serotypes (15A, 15C, 16F, 23A, 23B, 24F, 31 and 35B) Causing Invasive Pneumococcal Disease in Adult Patients in Canada: SAVE Study, 2018–21 Open Access." Journal of Antimicrobial Chemotherapy (JAC) 80, no. 5 (2025): 1377. https://doi.org/10.1093/jac/dkaf085.

MLA (9th ed.) Citation

Schellenberg, John J., et al. "Comparing Serotype Coverage of Pneumococcal Vaccines with PCV21 (V116), a New 21-valent Conjugate Pneumococcal Vaccine, and the Epidemiology of Its Eight Unique Streptococcus Pneumoniae Serotypes (15A, 15C, 16F, 23A, 23B, 24F, 31 and 35B) Causing Invasive Pneumococcal Disease in Adult Patients in Canada: SAVE Study, 2018–21 Open Access." Journal of Antimicrobial Chemotherapy (JAC), vol. 80, no. 5, 2025, p. 1377, https://doi.org/10.1093/jac/dkaf085.